Ziritaxestat

Item number	Size	Delivery time	Price
TGM-T4041-5mg	5 mg	7 - 10 business days*	41.00€
TGM-T4041-1mL	1 ml	7 - 10 business days*	53.00€
TGM-T4041-10mg	10 mg	7 - 10 business days*	68.00€
TGM-T4041-25mg	25 mg	7 - 10 business days*	114.00€
TGM-T4041-50mg	50 mg	7 - 10 business days*	187.00€
TGM-T4041-100mg	100 mg	7 - 10 business days*	348.00€
TGM-T4041-200mg	200 mg	7 - 10 business days*	519.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Ziritaxestat (GLPG1690), an autotaxin inhibitor, currently being evaluated in an... more

Close menu

Product information "Ziritaxestat"

Description: Ziritaxestat (GLPG1690), an autotaxin inhibitor, currently being evaluated in an exploratory phase 2 study in idiopathic pulmonary fibrosis patients. Target: PDE. Smiles: CCc1nc2c(C)cc(cn2c1CNc1nc(c(s1)C#N)-c1ccc(F)cc1)N1CCN(CC(=O)N2CC(O)C2)CC1. References: Desroy N., et al. Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinicalal Evaluation for the Treatment of Idiopathic PulmoN/Ary Fibrosis. J Med Chem. 2017 May 11,60(9):3580-3590.

Keywords:	GLPG1690
Supplier:	TargetMol
Supplier-Nr:	T4041

Properties

Application:	Targets ectonucleotide pyrophosphatase/phosphodiesterase family member 2 [EC:3.1.4.39] (ENPP2)
MW:	588.7 D
Formula:	C30H33FN8O2S
Format:	32160405